Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels.
Katz DA, Grimm DR, Cassar SC, Gentile MC, Ye X, Rieser MJ, Gordon EF, Polzin JE, Gustavson LE, Driscoll RM, O'dea RF, Williams LA, Bukofzer S. Katz DA, et al. Among authors: grimm dr. Clin Pharmacol Ther. 2004 Jun;75(6):516-28. doi: 10.1016/j.clpt.2004.01.013. Clin Pharmacol Ther. 2004. PMID: 15179406 Clinical Trial.
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.
Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ. Donawho CK, et al. Among authors: grimm dr. Clin Cancer Res. 2007 May 1;13(9):2728-37. doi: 10.1158/1078-0432.CCR-06-3039. Clin Cancer Res. 2007. PMID: 17473206
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies.
Yee KW, Hagey A, Verstovsek S, Cortes J, Garcia-Manero G, O'Brien SM, Faderl S, Thomas D, Wierda W, Kornblau S, Ferrajoli A, Albitar M, McKeegan E, Grimm DR, Mueller T, Holley-Shanks RR, Sahelijo L, Gordon GB, Kantarjian HM, Giles FJ. Yee KW, et al. Among authors: grimm dr. Clin Cancer Res. 2005 Sep 15;11(18):6615-24. doi: 10.1158/1078-0432.CCR-05-0650. Clin Cancer Res. 2005. PMID: 16166440 Clinical Trial.
The utility of ChatGPT as a generative medical translator.
Grimm DR, Lee YJ, Hu K, Liu L, Garcia O, Balakrishnan K, Ayoub NF. Grimm DR, et al. Eur Arch Otorhinolaryngol. 2024 May 5. doi: 10.1007/s00405-024-08708-8. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38705894
SNOT-22 subdomain outcomes following treatment for sinonasal malignancy: A prospective, multicenter study.
Grimm DR, Beswick DM, Maoz SL, Wang EW, Choby GW, Kuan EC, Chan EP, Adappa ND, Geltzeiler M, Getz AE, Humphreys IM, Le CH, Abuzeid WM, Chang EH, Jafari A, Kingdom TT, Kohanski MA, Lee JK, Nayak JV, Palmer JN, Patel ZM, Pinheiro-Neto CD, Resnick AC, Sim MS, Smith TL, Snyderman CH, John MA St, Storm P, Suh JD, Wang MB, Hwang PH. Grimm DR, et al. Int Forum Allergy Rhinol. 2024 Feb 19. doi: 10.1002/alr.23338. Online ahead of print. Int Forum Allergy Rhinol. 2024. PMID: 38372441
Factors Associated With Otolaryngologists Performing Tracheotomy.
Soliman SI, Panuganti BA, Francis DO, Pang J, Klebaner D, Asturias A, Alattar A, Wood S, Terry M, Bryson PC, Tipton CB, Zhao EE, O'Rourke A, Santa Maria C, Grimm DR, Sung CK, Lao WP, Thompson JM, Crawley BK, Rosen S, Berezovsky A, Kupfer R, Hennesy TB, Clary M, Joseph IT, Sarhadi K, Kuhn M, Abdel-Aty Y, Kennedy MM, Lott DG, Weissbrod PA. Soliman SI, et al. Among authors: grimm dr. JAMA Otolaryngol Head Neck Surg. 2023 Dec 1;149(12):1066-1073. doi: 10.1001/jamaoto.2023.2698. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37796485
49 results